跳至主要内容
临床试验/NCT05600751
NCT05600751招募中不适用

Radiosurgery of Ganglion StELlatum In Patients With REFractory Angina Pectoris

University Hospital Ostrava2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2022年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10
试验地点
2
主要终点
Safety of radiosurgery of ganglion stellatum

研究概览

简要总结

The core hypothesis to be tested is that the radiosurgery of stellate ganglion (left one or both if left-sided without full relief of symptoms) is an effective therapy of refractory angina pectoris in patients with no other therapeutic options - proof of concept study.

详细描述

Design: prospective, interventional trial (University Hospital Ostrava, Cardiocentre AGEL Podlesi Hospital Trinec)

  • radiosurgery of left GS after confirmation of responding to anesthetic blockade
  • in case of remaining AP after three months, radiosurgery of right GS in case of response confirmation to anesthetic blockade (patients must be responders of anesthetic blockade of left stellate ganglion)
  • Seattle Angina Questionary (SAQ) and amount of nitrate usage for responding confirmation
  • Radiotherapy 40 Gy
  • 2-year follow-up
  • Scheduled follow-up visits: 1, 3, 6, 12, and 24 months (24)

Preliminary examination: selective coronary angiography, transthoracic echocardiography, stress test, 6 min walk test, SAQ (19-item)

Endopoints:

Primary Endpoints: SAQ, safety of the radiosurgery of GS Secondary Endpoints:usage decrease of angina relief drugs, 6 min walk test improvement

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients must have coronary artery disease (CAD) with refractory angina pectoris (AP).
  • •Patients must have a maximum of tolerated medication therapy of angina pectoris available.
  • •Patients must have done the maximum possible revascularization of CAD.
  • •Two certificated independent interventional cardiologists and two cardiac surgeons must conclude that further revascularization (including CABG) is not possible/not effective/ with high risk.
  • •Age ≥ 18 years.
  • •Patients must have any stress test with proof of myocardial ischemia (dobutamine echocardiography, gated Tc-SPECT of myocardium).
  • •Life expectancy at least 24 months (not limited due to severe comorbidities)
  • •Patients must be responders of anesthetic blockade of the left stellate ganglion (GS) - clinically significant relief of AP symptoms after blockade at least twice.
  • •Patients must provide verbal and written informed consent to participate in the study.

排除标准

  • •Life expectancy less than 24 months
  • •Non-responders of anesthetic blockade of GS
  • •Impossibility to undergo a stress test.
  • •Myocardial infarction in last 4 weeks
  • •Heart failure - class IV NYHA
  • •Unwillingness to participate or inability to comply with the protocol for the duration of the study
  • •Patients who are pregnant, and patients with reproductive capability will need to use adequate contraception during the time of participation in the study
  • •History of radiotherapy in the head and neck region

研究组 & 干预措施

Radiosurgery of Ganglion Stellatum

Experimental

Patients will undergo radiosurgery of the ganglion stellatum (left one or both)

干预措施: Radiosurgery of ganglion stellatum (Procedure)

结局指标

主要结局

Safety of radiosurgery of ganglion stellatum

时间窗: 24 months

Safety of radiosurgery of ganglion stellatum will be observed and assessed according to the occurrence of adverse events

Seattle Angina Questionnaire

时间窗: 24 months

The Seattle Angina Questionnaire is a cardiac disease-related quality-of-life measure with 19 items. A lower score corresponds to a lower level of functioning. The scores are classified as "minimal (scores 75-100), mild (50-74), moderate (25-49), and severe (0-24).

次要结局

  • Usage of angina pectoris relief drugs(24 months)
  • Six-minute walk test improvement(24 months)

研究者

发起方
University Hospital Ostrava
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验